Stoffels IMC
The computed 12-month bankruptcy probability of Stoffels IMC is 0.6% (low). The 2024 annual accounts show equity of €3.40M and a net result of €1.64M. Equity is shrinking by ~20.5% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2027. Its solvency ranks better than 85% of 1395 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €3.40M |
| Net result | €1.64M |
| Staff (FTE) | 1.7 |
| Better than sector | 85% |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 80.2% | 43.6% | |
| Net result | €1.64M | €41k | |
| Equity | €3.40M | €163k | |
| Gross operating margin | €2.51M | €72k | |
| Staff costs | €273k | €106k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €2.24M |
| Net profit | €1.64M |
| Cash flow | €1.66M |
| Staff costs | €273k |
| Income taxes | €767k |
| Dividends | - |
| Total assets | €4.24M |
| Equity | €3.40M |
| Debt | €841k |
| of which ≤ 1y | €841k |
| of which > 1y | - |
| Working capital | €3.25M |
| Employees (FTE) | 1.7 |
| 2024 | |
|---|---|
| Current ratio | 4.86 |
| Quick ratio | 4.86 |
| Working capital ratio | 76.6% |
| Solvency | 80.2% |
| Debt / equity | 0.25 |
| Long-term debt ratio | - |
| Interest coverage | 197.35 |
| Gross margin | - |
| Net margin | - |
| ROA | 38.6% |
| ROE | 48.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €4.24M |
| Fixed assets | 21/28 | €151k |
| Tangible fixed assets | 22/27 | €149k |
| Financial fixed assets | 28 | €1k |
| Current assets | 29/58 | €4.09M |
| Amounts receivable within one year | 40/41 | €1.46M |
| Cash & bank | 54/58 | €2.31M |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €4.24M |
| Equity | 10/15 | €3.40M |
| Contributions / capital | 10/11 | €50k |
| Reserves | 13 | €3.35M |
| Amounts payable | 17/49 | €841k |
| Amounts payable within one year | 42/48 | €841k |
| Trade debts payable within one year | 44 | €62k |
| Income statement | ||
| Gross operating margin | 9900 | €2.51M |
| Operating result | 9901 | €2.21M |
| Financial income | 75 | €202k |
| Financial charges | 65 | €11k |
| Result before taxes | 9903 | €2.41M |
| Income taxes | 67/77 | €767k |
| Net result for the period | 9904 | €1.64M |
| Result to be appropriated | 9905 | €1.64M |
| NACE primary | Head offices & management consulting(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 26-01-2022 |
| Status | Active |
| Postal code | 1000 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21803C0366/00H000 | Brussels | 412 m² | 1 · 325 m² | 17.4 m · 5 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
01-07-2026 Act object · Notarial deed · Incorporation · Founder
- Act object: OPRICHTING · ARMED CELL THERAPEUTICS
- Publication: 01/07/2026 · ARMED CELL THERAPEUTICS
- Filing: 29-06-2026 · ARMED CELL THERAPEUTICS
- Notarial deed: 26 juni 2026 · ARMED CELL THERAPEUTICS
- Incorporation: 26 juni 2026 · ARMED CELL THERAPEUTICS
- Founder · Paul Stoffels
- Founder · John Mellors
- Founder · Peter Verhaeghe
- Founder · ALBA HOLDING BV
- Founding capital: amount: 23801.0, shares: 23801, currency: EUR · ARMED CELL THERAPEUTICS
- Bank account: KBC · ARMED CELL THERAPEUTICS
- Purpose: De vennootschap heeft tot voorwerp, in België en in het buitenland, zowel voor eigen rekening als voor rekening van derden, alleen of in participatie met derden, • het ontplooien van diverse activiteiten die rechtstreeks of onrechtstreeks betrekking hebben op de onderzoek, ontwikkeling, productie en commercialisatie van geneesmiddelen en therapieën voor gebruik in mensen, planten en/of dieren; • het ontplooien van alle soorten industriële, financiële en commerciële activiteiten en diensten, inclusief maar niet beperkt tot (preklinisch en klinisch) onderzoek; • de verwerving, exploitatie en verhandeling van octrooien, handelsmerken, licenties, knowhow en andere industriële eigendomsrechten; • het ontplooien van diverse activiteiten die rechtstreeks of onrechtstreeks betrekking hebben op consultancy activiteiten en holding activiteiten. · ARMED CELL THERAPEUTICS
- Officer appointment: role: niet-statutair bestuurder, term: onbepaalde duur, start_date: datum verkrijging rechtspersoonlijkheid · Stoffels IMC BV
- Officer appointment: role: niet-statutair bestuurder, term: onbepaalde duur, start_date: datum verkrijging rechtspersoonlijkheid · John Mellors
- Officer appointment: role: niet-statutair bestuurder, term: onbepaalde duur, start_date: datum verkrijging rechtspersoonlijkheid · Peter Verhaeghe
- Permanent representative · Paul Stoffels
- Mandate compensation: onbezoldigd · Stoffels IMC BV
- Mandate compensation: onbezoldigd · John Mellors
- Mandate compensation: onbezoldigd · Peter Verhaeghe
- First fiscal year: end: 31 december 2027, start: datum verkrijging rechtspersoonlijkheid · ARMED CELL THERAPEUTICS
- Filing representative: formaliteiten bij alle ondernemingsloket, bij de Kruispuntbank voor Ondernemingen, UBO en, in voorkend geval, bij de diensten van de Belasting over de Toegevoegde Waarde · Emmanuel Casier
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Onderwerp akte : OPRICHTING",
"value": "OPRICHTING",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-01",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 01/07/2026",
"value": "01/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-06-29",
"type": "filing",
"quote": "Neergelegd 29-06-2026",
"value": "29-06-2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-06-26",
"type": "notarial_deed",
"quote": "Uit een akte verleden voor Estelle BOUFFIER, notaris te Brussel ... op 26 juni 2026",
"value": "26 juni 2026",
"object": "e7",
"subject": "e1"
},
{
"date": "2026-06-26",
"type": "incorporation",
"quote": "OPRICHTING ... op 26 juni 2026",
"value": "26 juni 2026",
"object": null,
"subject": "e1"
},
{
"type": "founder",
"quote": "1. De heer Paul Stoffels ... Hierna \u0022de comparanten\u0022 genoemd.",
"value": null,
"object": "e1",
"subject": "e2"
},
{
"type": "founder",
"quote": "2. De heer John Mellors ... Hierna \u0022de comparanten\u0022 genoemd.",
"value": null,
"object": "e1",
"subject": "e3"
},
{
"type": "founder",
"quote": "3. De heer Peter Verhaeghe ... Hierna \u0022de comparanten\u0022 genoemd.",
"value": null,
"object": "e1",
"subject": "e4"
},
{
"type": "founder",
"quote": "4. De besloten vennootschap ALBA HOLDING BV ... Hierna \u0022de comparanten\u0022 genoemd.",
"value": null,
"object": "e1",
"subject": "e5"
},
{
"type": "founding_capital",
"quote": "Het aanvangsvermogen is 23.801,- EUR. ... 23.801 aandelen ... 1,- EUR per stuk",
"value": {
"amount": 23801.0,
"shares": 23801,
"currency": "EUR",
"subscribers": [
{
"amount": "13.800",
"shares": 13800,
"entity_id": "e2"
},
{
"amount": "5.000",
"shares": 5000,
"entity_id": "e3"
},
{
"amount": "5.000",
"shares": 5000,
"entity_id": "e4"
},
{
"amount": "1",
"shares": 1,
"entity_id": "e5"
}
]
},
"amount": 23801.0,
"object": null,
"subject": "e1",
"currency": "EUR",
"_value_raw": {
"amount": "23.801",
"shares": 23801,
"currency": "EUR",
"subscribers": [
{
"amount": "13.800",
"shares": 13800,
"entity_id": "e2"
},
{
"amount": "5.000",
"shares": 5000,
"entity_id": "e3"
},
{
"amount": "5.000",
"shares": 5000,
"entity_id": "e4"
},
{
"amount": "1",
"shares": 1,
"entity_id": "e5"
}
]
}
},
{
"type": "bank_account",
"quote": "gedeponeerd op een bijzondere rekening geopend namens de vennootschap in oprichting bij de bank KBC",
"value": "KBC",
"object": null,
"subject": "e1"
},
{
"type": "purpose",
"quote": "Artikel 3. Voorwerp",
"value": "De vennootschap heeft tot voorwerp, in Belgi\u00EB en in het buitenland, zowel voor eigen rekening als voor rekening van derden, alleen of in participatie met derden, \u2022 het ontplooien van diverse activiteiten die rechtstreeks of onrechtstreeks betrekking hebben op de onderzoek, ontwikkeling, productie en commercialisatie van geneesmiddelen en therapie\u00EBn voor gebruik in mensen, planten en/of dieren; \u2022 het ontplooien van alle soorten industri\u00EBle, financi\u00EBle en commerci\u00EBle activiteiten en diensten, inclusief maar niet beperkt tot (preklinisch en klinisch) onderzoek; \u2022 de verwerving, exploitatie en verhandeling van octrooien, handelsmerken, licenties, knowhow en andere industri\u00EBle eigendomsrechten; \u2022 het ontplooien van diverse activiteiten die rechtstreeks of onrechtstreeks betrekking hebben op consultancy activiteiten en holding activiteiten.",
"object": null,
"subject": "e1"
},
{
"type": "officer_appointment",
"quote": "Wordt benoemd tot niet-statutair bestuurder(s) voor een onbepaalde duur: \u2022 Stoffels IMC BV ... Deze benoeming zal maar uitwerking hebben op de dag van de verkrijging van de rechtspersoonlijkheid",
"value": {
"role": "niet-statutair bestuurder",
"term": "onbepaalde duur",
"start_date": "datum verkrijging rechtspersoonlijkheid"
},
"object": null,
"subject": "e6"
},
{
"type": "officer_appointment",
"quote": "Wordt benoemd tot niet-statutair bestuurder(s) voor een onbepaalde duur: ... \u2022 De heer John Mellors ... Deze benoeming zal maar uitwerking hebben op de dag van de verkrijging van de rechtspersoonlijkheid",
"value": {
"role": "niet-statutair bestuurder",
"term": "onbepaalde duur",
"start_date": "datum verkrijging rechtspersoonlijkheid"
},
"object": null,
"subject": "e3"
},
{
"type": "officer_appointment",
"quote": "Wordt benoemd tot niet-statutair bestuurder(s) voor een onbepaalde duur: ... \u2022 De heer Peter Verhaeghe ... Deze benoeming zal maar uitwerking hebben op de dag van de verkrijging van de rechtspersoonlijkheid",
"value": {
"role": "niet-statutair bestuurder",
"term": "onbepaalde duur",
"start_date": "datum verkrijging rechtspersoonlijkheid"
},
"object": null,
"subject": "e4"
},
{
"type": "permanent_representative",
"quote": "Stoffels IMC BV ... vast vertegenwoordigd door Paul Stoffels",
"value": null,
"object": "e6",
"subject": "e2"
},
{
"type": "mandate_compensation",
"quote": "hun opdracht zal kosteloos worden uitgeoefend",
"value": "onbezoldigd",
"object": null,
"subject": "e6"
},
{
"type": "mandate_compensation",
"quote": "hun opdracht zal kosteloos worden uitgeoefend",
"value": "onbezoldigd",
"object": null,
"subject": "e3"
},
{
"type": "mandate_compensation",
"quote": "hun opdracht zal kosteloos worden uitgeoefend",
"value": "onbezoldigd",
"object": null,
"subject": "e4"
},
{
"type": "first_fiscal_year",
"quote": "Het eerste boekjaar zal op de dag van de verkrijging van de rechtspersoonlijkheid door de vennootschap aanvangen en eindigen op 31 december 2027.",
"value": {
"end": "31 december 2027",
"start": "datum verkrijging rechtspersoonlijkheid"
},
"object": null,
"subject": "e1"
},
{
"type": "filing_representative",
"quote": "Alle machten worden verleend ... aan elke bestuurder individueel optredend, Emmanuel Casier ... ten einde de formaliteiten bij alle ondernemingsloket ... te verzekeren.",
"value": "formaliteiten bij alle ondernemingsloket, bij de Kruispuntbank voor Ondernemingen, UBO en, in voorkend geval, bij de diensten van de Belasting over de Toegevoegde Waarde",
"object": "e1",
"subject": "e8"
}
],
"act_meta": {
"outcome": "corrected",
"postfix": [
"primary company kbo missing -\u003E register 1039.592.451"
],
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 29005,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "1039.592.451",
"kind": "company",
"name": "ARMED CELL THERAPEUTICS",
"attrs": {
"seat": "Barricadenplein 13, 1000 Brussel",
"kbo_source": "register",
"legal_form": "Besloten Vennootschap",
"short_name": "ACTx"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Paul Stoffels",
"attrs": {
"address": "Avenue des Alpes 128, 1820 Montreux, Zwitserland"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "John Mellors",
"attrs": {
"address": "201 Beech Street, Pittsburgh, Pennsylvania 15218-1403, USA"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Peter Verhaeghe",
"attrs": {
"address": "Wilgenbaan 4, 1850 Grimbergen, Belgi\u00EB"
}
},
{
"id": "e5",
"kbo": "1038.846.046",
"kind": "company",
"name": "ALBA HOLDING BV",
"attrs": {
"seat": "Barricadenplein 13, 1000 Brussel"
}
},
{
"id": "e6",
"kbo": "0780.918.294",
"kind": "company",
"name": "Stoffels IMC BV",
"attrs": {
"seat": "Barricadenplein 13, 1000 Brussel"
}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Estelle BOUFFIER",
"attrs": {
"address": "1000 Brussel, de Lignestraat 13"
}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Emmanuel Casier",
"attrs": {
"address": "Barricadenplein 13, 1000 Brussel"
}
}
]
}17-10-2022 4 directors appointed, 1 resigning
- Katelijne Bruurs, Bestuurder
- Peter Verhaeghe, Dagelijks bestuur
- Emmanuel Casier, Dagelijks bestuur
- Yannick Vandenplas, Dagelijks bestuur
- Paul Stoffels, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Katelijne Bruurs",
"address": "Avenue des Alpes 158 bus B24, 1820 Montreaux, Zwitserland",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": true,
"effective_date": "2022-09-01",
"evidence_quote": "Op 31 augustus 2022 heeft de bijzondere algemene aandeelhoudersvergadering van Stoffels IMC BV besloten om mevrouw Katelijne Bruurs, wonende te Avenue des Alpes 158 bus B24, 1820 Montreaux, Zwitserland en met Belgische nationaliteit te benoemen als bestuurder van Stoffels IMC BV vanaf 1 september 20",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Stoffels",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": true,
"effective_date": "2022-09-01",
"evidence_quote": "Daarnaast besloten de aandeelhouders tjdens deze bijzondere algemene aandeelhoudersvergadering om het mandaat van de huidige bestuurder, baron Paul Stoffels, vanaf 1 september 2022 te bezoldigen.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Peter Verhaeghe",
"address": "Barricadenplein 13, 1000 Brussel",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "VWGB Advocaten|Avocats",
"address": "Barricadenplein 13, 1000 Brussel",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Tot slot besloot deze bijzondere algemene aandeelhoudersvergadering om volmacht te verlenen aan VWGB Advocaten|Avocats, en in het bijzonder aan de heren Peter Verhaeghe, Emmanuel Casier en Yannick Vandenplas, ieder kantoorhoudend te Barricadenplein 13, 1000 Brussel en elk met de mogelijkheid om indi",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Emmanuel Casier",
"address": "Barricadenplein 13, 1000 Brussel",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "VWGB Advocaten|Avocats",
"address": "Barricadenplein 13, 1000 Brussel",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Tot slot besloot deze bijzondere algemene aandeelhoudersvergadering om volmacht te verlenen aan VWGB Advocaten|Avocats, en in het bijzonder aan de heren Peter Verhaeghe, Emmanuel Casier en Yannick Vandenplas, ieder kantoorhoudend te Barricadenplein 13, 1000 Brussel en elk met de mogelijkheid om indi",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Yannick Vandenplas",
"address": "Barricadenplein 13, 1000 Brussel",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "VWGB Advocaten|Avocats",
"address": "Barricadenplein 13, 1000 Brussel",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Tot slot besloot deze bijzondere algemene aandeelhoudersvergadering om volmacht te verlenen aan VWGB Advocaten|Avocats, en in het bijzonder aan de heren Peter Verhaeghe, Emmanuel Casier en Yannick Vandenplas, ieder kantoorhoudend te Barricadenplein 13, 1000 Brussel en elk met de mogelijkheid om indi",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Brussel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2022-10-17",
"filing_date": "2022-10-07",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "bijzondere_algemene_vergadering",
"date": "2022-08-31",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0780.918.294",
"name_full": "Stoffels IMC BV",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter Verhaeghe",
"org_rep_person_name": null,
"person_role_at_subject": "Bijzonder gevolmachtigde"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}27-04-2022 Capital increase of €5,222,028 to €5,222,028
Technical details
{
"events": [
{
"kind": "agio_incorporation",
"after_eur": 5222028.0,
"delta_eur": 5222028.0,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": 5222028.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "Matthieu DERYNCK",
"firm_city": null,
"firm_name": "Van Halteren, geassocieerde notarissen",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2022-04-20",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2022-04-13",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2022-04-13"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0780.918.294",
"name_full": "STOFFELS IMC",
"legal_form": "Besloten vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expeditie",
"volmacht",
"bankattest"
],
"shareholders_after": [],
"share_classes_after": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | Stoffels IMC |
| Legal nameNL | Stoffels IMC |